MiP MiP

The union for health and care managers

Home  >  News & Campaigns  >  Features  >  The Sharp End: The NHS must be smart about digital tech
Thursday 22 November 2018

The NHS must be smart about digital tech

By Anonymous

Telemedicine could bring huge benefits but, managed badly, we could end up combining the worst aspects of private healthcare and public-sector IT.

Sharp-End_2018-10-22_Digital-tech_Illo
I trained as a doctor – and while working in hospitals I was struck by how little technology doctors used in their working lives. Yet digital tech could dramatically transform healthcare.

For some years, I’ve worked with healthcare businesses on improving the delivery of care. I help digital health start-ups to understand the sector and develop their business models, and I advise investors and health providers on where to put their money.

Some digital technologies can be really powerful. For instance, lots of people with mental health problems struggle to access cognitive behavioural therapy (CBT) via the NHS. But Sleepio, a British company (not a client of mine) has created an app providing CBT for insomnia. Crucially, it’s really evidence-based: they’ve published dozens of peer-reviewed trials and papers, most recently in JAMA, the journal of the American Medical Association.

The new health secretary is excited about technology: he wants to move on from the traumatic experience of the National Programme for IT, which left many health organisations wary. But I don’t think he’s understood some of the risks with getting private businesses involved in delivering services.

Some of those risks hit home when Circle Holdings took over the running of Hinchingbrooke Hospital in 2012. Circle’s 10-year deal let the company take out the first £2m of any annual surplus plus a percentage of any further profits, but its total losses over the contract were capped at £5m. As it turns out, they got an ‘inadequate’ rating from the CQC and walked away when their losses hit the cap. There are lessons there about ensuring there is a level playing field and that business models work in patients’ interests. We must also prevent private companies from ‘cherry picking’ those patients least likely to suffer complications, leaving the NHS with the riskier, more expensive cases.

In assessing new tech, we should demand really strong medical evidence – and remember that private companies present data to sell their services, not to provide an objective picture. There’s evidence that some telemedicine systems can increase treatment rates without improving outcomes – so providers are paid to deliver interventions that provide no benefits. And there can be a higher risk of false positives or negatives: an analysis in JAMA Dermatology found that mole-checking apps intended to screen for melanoma returned 30% false negatives, which is really dangerous.

All these issues can come together in systems which offer medical assessments online. Some are linked to GP practices, and attract young, time-poor professionals who are rarely ill; that can be a form of cherry-picking, when patients are required to withdraw from NHS practices. And some have business models where they get paid for prescribing treatments, creating dangerous incentives.

Ali Parsa, Circle’s former chief executive, now runs the telemedicine company Babylon. In January, the British Medical Journal reported that Babylon’s app GP at Hand appeared to be increasing acute care activity – driving up CCG spending. Babylon’s artificial intelligence symptom checker hasn’t been properly clinically validated, and GP at Hand is currently being evaluated; yet the health secretary has visited its HQ and given it his personal backing. For every new service, it’s really important to scrutinise the business model carefully and act only when we’re really confident about the evidence base.

In fact, I wish NHS bodies were more willing to follow the evidence when it does show a benefit. Too many trusts and CCGs will only buy a system if they’ve run the trial themselves: there’s a crazy rivalry where they’re not interested in anything that one of their peers is using. So, even after a successful trial, many tech start-ups can’t get more sales, and investors lose faith in the sector. That’s a huge missed opportunity, given how easily scalable many of these services are.

There are loads of brilliant health tech businesses out there. And if we ensure that effective, proven technologies that improve patient outcomes and cut costs find a ready market across the NHS, that’ll send the right signal to investors – who’ll then fund the right technologies and business models. But if we’re not scrupulous and hard-nosed enough, trusts and CCGs could end up buying products that funnel taxpayers’ money out of the NHS without improving outcomes.

Hinchingbrooke turned the public against privately-run NHS hospitals, and the National Programme for IT stymied progress on information technology for a decade; we face the same risk now with digital health. And it would be a tragedy if we inoculated the NHS against these technologies, because they have huge potential. So, we need to be vigilant about finding the right partners, understanding their business models – and following the evidence, not the PR.

The Sharp End is your chance to tell politicians and civil servants how their policies affect your work and your organisation. Most stories are also published in the Guardian. To work with a reporter on your own story, email editor@healthcare-manager.co.uk. When requested, anonymity is guaranteed.

If you enjoyed this article, please sign up to receive our free monthly emails - and we’ll keep you up to date on news and events in health and care management

Sharp-End_2018-10-22_Digital-tech_Illo

Telemedicine could bring huge benefits but, managed badly, we could end up combining the worst aspects of private healthcare and public-sector IT.

22 November 2018 | By Anonymous
The Sharp End
The Sharp End Cartoon

Integration could transform our health and care services, argues one social care manager, but time is pressing and demand is constantly growing.

27 July 2018 | By Anonymous
The Sharp End
Sharp End_2018-04-18_Outsourcing_Cartoon

The Carillion collapse shows the perils of driving suppliers to the brink...

18 April 2018 | By Anonymous
The Sharp End

In today's NHS, we know it's crucial to protect people who raise the alarm about poor patient care or incompetent staff. But it's just as vital to avoid giving cover to people with axes to grind – as one innocent NHS manager discovered.

30 October 2017 | By Anonymous
The Sharp End
Sharp End_2016-09-23_STPs_Cartoon

A lack of drive and serious commitment to engaging the public is threatening to undermine STPs before they’ve really got started, warns one programme manager.

23 September 2017 | By Anonymous
The Sharp End
Sharp End_15-09-2017_35_system change_cartoon

Dean Royles, director of HR and organisational development at Leeds Teaching Hospitals, calls for a more streamlined system to run the NHS in England.

22 September 2017 | By Dean Royles
The Sharp End
Sharp End_2017-07-05_Scots Nats_Cartoon

One senior manager says the SNP government deserves credit for its realistic and supportive approach to reforming Scotland’s NHS.

05 July 2017 | By Anonymous
The Sharp End
Sharp End_2017-03-30_Leaders_Cartoon

The needs of the health service have changed dramatically in recent years but, says one NHS leadership coach, many leaders are stuck in an empire-building mindset. They must junk their instinct to compete – and learn to collaborate.

30 March 2017 | By Anonymous
The Sharp End
Sharp End_2016-11-22_Redeployment

The NHS’s redeployment policies are hugely wasteful of both management talent and public money, argues one MiP member.

22 November 2016 | By Anonymous
The Sharp End
Find us
FDA MiP section, 6th floor, Elizabeth House, 39 York Road, London, SE1 7NQ
Copyright © 2018 MiP